IRIS - Res&Arch Institutional Research Information System - Research & Archive

CIPRIANI, Sabrina
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.815
AS - Asia 1.968
EU - Europa 1.696
SA - Sud America 298
AF - Africa 46
OC - Oceania 4
Totale 6.827
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.747
SG - Singapore 950
IE - Irlanda 320
IT - Italia 295
CN - Cina 287
RU - Federazione Russa 247
HK - Hong Kong 241
BR - Brasile 233
VN - Vietnam 216
UA - Ucraina 157
FR - Francia 131
SE - Svezia 127
DE - Germania 94
FI - Finlandia 93
GB - Regno Unito 64
IN - India 54
TR - Turchia 50
EE - Estonia 36
CA - Canada 32
KR - Corea 27
PL - Polonia 25
AR - Argentina 24
MX - Messico 24
BD - Bangladesh 21
JP - Giappone 17
IQ - Iraq 16
CH - Svizzera 15
AT - Austria 14
ES - Italia 14
NL - Olanda 14
PK - Pakistan 14
RO - Romania 14
UZ - Uzbekistan 13
ZA - Sudafrica 13
EC - Ecuador 11
PH - Filippine 11
BE - Belgio 10
CO - Colombia 10
CZ - Repubblica Ceca 9
ID - Indonesia 8
LB - Libano 7
SA - Arabia Saudita 7
EG - Egitto 6
KE - Kenya 6
VE - Venezuela 6
CL - Cile 5
GR - Grecia 4
LT - Lituania 4
CR - Costa Rica 3
DZ - Algeria 3
ET - Etiopia 3
HN - Honduras 3
KG - Kirghizistan 3
MA - Marocco 3
MY - Malesia 3
NP - Nepal 3
PA - Panama 3
PE - Perù 3
PY - Paraguay 3
TN - Tunisia 3
TW - Taiwan 3
AU - Australia 2
BN - Brunei Darussalam 2
HU - Ungheria 2
IL - Israele 2
JO - Giordania 2
NG - Nigeria 2
NO - Norvegia 2
PS - Palestinian Territory 2
SN - Senegal 2
TH - Thailandia 2
UY - Uruguay 2
AL - Albania 1
AO - Angola 1
AZ - Azerbaigian 1
BF - Burkina Faso 1
CI - Costa d'Avorio 1
CV - Capo Verde 1
DO - Repubblica Dominicana 1
IR - Iran 1
JM - Giamaica 1
KH - Cambogia 1
KZ - Kazakistan 1
LU - Lussemburgo 1
LY - Libia 1
MD - Moldavia 1
MN - Mongolia 1
NR - Nauru 1
OM - Oman 1
PT - Portogallo 1
PW - Palau 1
QA - Qatar 1
RS - Serbia 1
SR - Suriname 1
SV - El Salvador 1
Totale 6.827
Salva come PNG Salva come JPEG
Città #
Singapore 718
Chandler 396
Dublin 319
San Jose 303
Hong Kong 240
San Mateo 193
Ashburn 169
Dong Ket 134
Perugia 109
Santa Clara 107
Boardman 101
Moscow 93
Beijing 91
Ann Arbor 90
Altamura 88
Medford 78
Princeton 78
Jacksonville 69
Lawrence 69
Lauterbourg 67
Wilmington 64
Andover 63
Los Angeles 51
Columbus 33
Izmir 32
São Paulo 31
New York 30
The Dalles 30
Des Moines 27
Saint Petersburg 27
Seoul 27
Ho Chi Minh City 25
Munich 23
Helsinki 22
Dearborn 21
Orem 21
Warsaw 18
Houston 16
Tokyo 16
Hanoi 15
Timisoara 14
Chennai 13
London 13
Stockholm 13
Frankfurt am Main 12
San Paolo di Civitate 12
Dallas 11
Norwalk 11
Redmond 11
Rio de Janeiro 11
Rome 11
Brussels 10
Chicago 10
Falls Church 10
Johannesburg 10
Manchester 10
Nuremberg 10
Denver 9
Montreal 9
Toronto 9
Vienna 9
Woodbridge 9
Den Haag 8
Mexico City 8
Turku 8
Ankara 7
Baghdad 7
Council Bluffs 7
Olomouc 7
Redwood City 7
Tashkent 7
Boston 6
Guayaquil 6
New Delhi 6
Phoenix 6
Brooklyn 5
Buffalo 5
Nairobi 5
Ottawa 5
Paris 5
Ribeirão Preto 5
Shanghai 5
Campinas 4
Da Nang 4
Dhaka 4
Nanjing 4
Ninh Bình 4
Piscataway 4
Quito 4
San Francisco 4
Seattle 4
Addis Ababa 3
Amsterdam 3
Atlanta 3
Bexley 3
Bishkek 3
Bắc Ninh 3
Cairo 3
Carney 3
Chandigarh 3
Totale 4.529
Salva come PNG Salva come JPEG
Nome #
Activation of the bile acid receptor GPBAR1 protects against gastrointestinal injury caused by non-steroidal anti-inflammatory drugs and aspirin in mice. 146
Anti-HIV Protease Inhibitors Interact With NSAIDs and Exacerbate Small Intestine Enteropathy Induced by NSAIDs 145
The bile acid receptor GPBAR1 (TGR5) is expressed in human gastric cancers and promotes epithelial-mesenchymal transition in gastric cancer cell lines 144
A Comprehensive Analysis of Small Heterodimer Partner (SHP) Target Genes in Hepatic Stellate Cells and the Discovery of a New Class of SHP Agonists That Reduces Liver Fibrosis 140
The bile acid receptor GPBAR1 regulates the M1/M2 phenotype of intestinal macrophages and activation of gpbar1 rescues mice from murine colitis 139
BAR502, a Dual FXR and GPBAR1 Agonist, Reverses Steatosis and Fibrosis in Rodent Model of NASH By Modulating Authophagic Genes 136
Bile acid-activated receptors in the treatment of dyslipidemia and related disorders. 135
Activation of the farnesoid-X receptor protects against gastrointestinal injury caused by non-steroidal anti-inflammatory drugs in mice. 130
Microencapsulated G3C hybridoma cell graft delays the onset of spontaneous diabetes in NOD mice by an expansion of Gitr+ Treg cells 130
Activation of FXR Improves Myocardial Fatty Acid Metabolism in a Rodent Model of Liver Steatosis 127
Leflunomide protects against dyslipidemia development induced by ritonavir in mice 122
BAR 501, a Novel GPBAR1 Ligand, Reverses Intestinal and Liver Inflammatory Models Demonstrating That GPBAR1 Is an Essential Modulator of Innate Immunity in Entero-Hepatic Tissues 122
Efficacy of the CCR5 antagonist maraviroc in reducing early, ritonavir-induced atherogenesis and advanced plaque progression in mice. 119
Dissociation of intestinal and hepatic activities of FXR and LXRα supports metabolic effects of terminal ileum interposition in rodents. 110
BAR501, A SELECTIVE GPBAR1 AGONIST, PROMOTES ADIPOSE TISSUE BROWNING AND AUTOPHAGY AND IMPROVES LIPID METABOLISM AND STEATO-HEPATITIS IN MICE FEED A HIGH FAT DIET 109
A Platelet's Guide to Synovitis 109
Genetic and Pharmacological Dissection of the Role of Spleen Tyrosine Kinase (Syk) in Intestinal Inflammation and Immune Dysfunction in Inflammatory Bowel Diseases 104
Glucocorticoid receptor mediates the gluconeogenic activity of the farnesoid X receptor in the fasting condition 103
BAR502, a dual FXR and GPBAR1 agonist, promotes browning of white adipose tissue and reverses liver steatosis and fibrosis 103
Bile acid activated receptors are targets for regulation of integrity of gastrointestinal mucosa 102
BAR130, A HYODEOXYCHOLIC ACID DERIVATIVE AS THE FIRST EXAMPLE OF DUAL LXR alpha/GPBAR1 AGONIST 101
Development of non-antibiotic macrolide that corrects inflammation-driven immune dysfunction in models of inflammatorybowel diseases and arthritis 99
Counter-regulatory role of bile acid activated receptors in immunity andinflammation. 99
Probiotics modulate intestinal expression of nuclear receptor and provide counter-regulatory signals to inflammation-driven adipose tissue activation. 96
Maraviroc Intensification Modulates Atherosclerotic Progression in HIV-Suppressed Patients at High Cardiovascular Risk. A Randomized, Crossover Pilot Study 95
A Novel Source of Intestinal Damage: The HIV Protease Inhibitor Ritonavir Worsens Damage Caused by COX Inhibitors 93
Genetic Ablation and Pharmacological Blockade of CCR5 by the anti-HIV Small Molecule Inhibitor Maraviroc Inhibits Leukocyte Trafficking and Protects Against Mucosal Inflammation in Murine Models Colitis 93
Discovery that theonellasterol a marine sponge sterol is a highly selective FXR antagonist that protects against liver injury in cholestasis. 93
The bile acid sensor farnesoid X receptor is a modulator of liver immunity in a rodent model of acute hepatitis. 91
The HIV Matrix Protein p17 subverts Nuclear Receptors Expression and induces a STAT1-Dependent Proinflammatory Phenotype in Monocytes 91
Farnesoid X receptor suppresses constitutive androstane receptoractivity at the multidrug resistance protein-4 promoter. 90
DISCOVERY OF BAR704, A POTENT AND SELECTIVE FXR AGONIST, THAT PROTECTS AGAINST LIVER FIBROSIS 90
The bile acid receptor GPBAR-1 (TGR5) modulates integrity of intestinal barrier and immune response to experimental colitis. 89
The bile acid sensor FXR protects against dyslipidemia and aortic plaques development induced by the HIV protease inhibitor ritonavir in mice. 88
Ritonavir-induced lipoatrophy and dyslipidaemia is reversed by the anti-inflammatory drug leflunomide in a PPAR-γ-dependent manner. 88
Metabolic variability of a multispecies probiotic preparation impacts on the anti-inflammatory activity 88
Bile-acid-activated receptors: targeting TGR5 and farnesoid-X-receptor in lipid and glucose disorders. 88
FXR mediates a chromatin looping in the GR promoter thus promoting the resolution of colitis in rodents. 87
Nanotraps with biomimetic surface as decoys for chemokines 85
The HIV Matrix Protein p17 promotes the Activation of human hepatic stellate cells through interactions with CXCR2 and Syndecan-2 84
CCR5 Antagonism by Maraviroc Reduces the Potential for Gastric Cancer Cell Dissemination. 84
Gpbar1 agonism promotes a Pgc-1α-dependent browning of white adipose tissue and energy expenditure and reverses diet-induced steatohepatitis in mice 84
Targetting farnesoid-X-receptor: from medicinal chemistry to disease treatment. 83
Cystathionine gamma-lyase, a H2S-generating enzyme, is a GPBAR1-regulated gene and contributes to vasodilation caused by secondary bile acids 82
The Leukemic Isocitrate Dehydrogenase (IDH) 1/2 Mutations Impair Myeloid and Erythroid Cell Differentiation of Primary Human Hematopoietic Stem and Progenitor Cells (HSPCs) 81
Farnesoid X receptor agonist for the treatment of liver and metabolic disorders: focus on 6-ethyl-CDCA 81
Exploitation of cholane scaffold for the discovery of potent and selective farnesoid X receptor (FXR) and G-protein coupled bile acid receptor 1 (GP-BAR1) ligands 81
The nuclear receptor FXR regulates hepatic transport and metabolism of glutamine and glutamate 80
Impaired Itching Perception in Murine Models of Cholestasis Is Supported by Dysregulation of GPBAR1 Signaling 80
VARIABILITY IN INDUSTRIAL PRODUCTION AFFECTS PROBIOTICS ACTIVITY: IDENTIFICATION OF BATCHES OF PROBIOTIC VSL#3 THAT INCREASES INTESTINAL PERMEABILITY AND WORSENS COLITIS IN RODENTS 77
In vivo administration of ritonavir worsens intestinal damage caused by cyclooxygease inhibitors. 75
Decoding the role of the nuclear receptor SHP in regulating hepatic stellate cells and liver fibrogenesis 75
Modulation of intestinal microbiota by the probiotic VSL#3 resets brain gene expression and ameliorates the age-related deficit in LTP. 73
Hydrogen sulphide induces micro opioid receptor-dependent analgesia in a rodent model of visceral pain. 72
SHP-dependent and -independent induction of peroxisomeproliferator-activated receptor-γ by the bile acid sensor farnesoid X receptorcounter-regulates the pro-inflammatory phenotype of liver myofibroblasts. 72
Instruction of Intestinal Microbiota by VSL#3 Reverses NASH and Accelerated Atherosclerosis Caused by Intestinal Inflammation in ApoE(-/-) Mice 71
GPBAR1 (TGR5) LIGATION PROTECTS AGAINST COLITIS DEVELOPMENT BY REGULATING LEUKOCYTE TRAFFINKING AND PROMOTING A IL-10 DEPENDENT SHIFT IN THE M1/M2 PHENOTYPE 71
Pregnane-X-receptor mediates the anti-inflammatoryactivities of rifaximin on detoxification pathways in intestinal epithelialcells. 70
H2S Induces Analgesia Is Mediated In Vivo Activation of mu Opioid Receptor and PI3K/AKT Pathway Activation 70
Solomonsterol A, a marine pregnane-X-receptor agonist, attenuates inflammation and immune dysfunction in a mouse model of arthritis. 69
Targeting Bile Acid Receptors: Discovery of a Potent and Selective Farnesoid X Receptor Agonist as a New Lead in the Pharmacological Approach to Liver Diseases 69
FXR Activation Reverses Insulin Resistance and Protects Against NASH Development 68
Methotrexate improves endothelial function in early rheumatoid arthritis patients after 3 months of treatment 67
The HIV matrix protein p17 induces hepatic lipid accumulation via modulation of nuclear receptor transcriptoma 67
Role of Maraviroc in a dyslipidemic murine model of atherosclerosis RTV-induced 66
Essential Role of DNAX Adaptor Protein 12 (DAP12) and Spleen Tyrosine Kinase (Syk) in Inflammation-Driven Immune Dysfunction in Rodent Model of Colitis 62
Reversal of Endothelial Dysfunction by GPBAR1 Agonism in Portal Hypertension Involves a AKT/FOXOA1 Dependent Regulation of H2S Generation and Endothelin-1 62
Highly specific blockade of CCR5 inhibits leukocyte trafficking and reduces mucosal inflammation in murine colitis 61
Preterm Birth, Low Gestational Age, Low Birth Weight, Parity, and Other Determinants of Breech Presentation: Results from a Large Retrospective Population-Based Study 60
Dietary habits and semen parameters: a systematic narrative review 59
The bile acid sensor FXR is required for immune-regulatory activities of TLR-9 in intestinal inflammation 58
The Bile Acid Receptor TGR5 Maintains Gastrointestinal Homeostasis and Its Activation Rescues From Gastrointestinal Injury Caused by ASA and NSAIDs 57
Probiotics VSL#3 protect against development of visceral pain in murine model of irritable bowel syndrome. 56
Modification on ursodeoxycholic acid (UDCA) scaffold. discovery of bile acid derivatives as selective agonists of cell-surface G-protein coupled bile acid receptor 1 (GP-BAR1). 53
VSL#3 Resets Insulin Signaling and Protects against NASH and Atherosclerosis in a Model of Genetic Dyslipidemia and Intestinal Inflammation. 52
Reciprocal Regulation of TLRS and Nuclear Receptors: IRF-7 Dependent Regulation of FXR Mediates Counter-Regulatory Effects of TLR-9 in Colitis 52
FXR Activation Corrects Immune-Dysfunction and Attenuates Inflammation in a Rodent Model of Hepatitis 48
Modification of Intestinal Microbiota by VSL#3 Protects Against Development of Pain in the Neonatal Maternal Separation Model. a Whole Genome Array Investigation 46
Mechanistic role of p38 MAPK in gastric cancer dissemination in a rodent model peritoneal metastasis. 45
Hyodeoxycholic acid derivatives as liver X receptor α and G-protein-coupled bile acid receptor agonists 44
EXTRAMEDULLARY INVOLVEMENT IN PATIENT-DERIVED XENOGRAFT MODELS OF ACUTE MYELOID LEUKEMIA (AML) WITH NUCLEOPHOSMIN (NPM-1) MUTATION 13
Totale 6.999
Salva come PNG Salva come JPEG
Categoria #
all - tutte 31.679
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.679
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021197 0 0 0 0 0 0 0 0 0 16 32 149
2021/2022676 7 132 2 34 31 7 14 223 8 32 85 101
2022/20231.223 81 243 7 124 115 116 0 62 431 1 32 11
2023/2024394 31 52 25 3 2 2 97 13 10 20 84 55
2024/20251.161 16 88 47 42 166 66 28 69 231 71 196 141
2025/20262.388 152 145 145 270 325 216 464 145 334 192 0 0
Totale 6.999